ArticleChemical science2026
Molecular reporters for mammalian sugars
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Glycans are essential transmitters of biological information. However, their complex and dynamic structures remain difficult to characterize, posing a major barrier to fully understanding their biological functions. Here, we demonstrate that hydrogen bonding auxiliaries positioned adjacent to the boron site of turn-on fluorogenic phenylboronic acid reporters serve as key modulators of sensitivity to mammalian sugars, providing a new design principle analogous to the hydrogen bonding networks found in lectin binding pockets. We show that these auxiliaries tune sensitivity both globally and for individual mammalian sugars and reveal a striking differential turn-on response between the anomeric forms of monosaccharides. The versatility of these selective and reversible molecular reporters is demonstrated through in-gel glycoprotein imaging, flow cytometry, and cell-surface visualization, establishing them as a generalizable chemical platform for interrogating mammalian glycans.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.